ATLASCompass Therapeutics (CMPX) earnings date: Nov 4, 2026
Compass Therapeutics (CMPX) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026. Analysts expect EPS of -$0.12.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CMPX
| Last price | $0.79 (+4.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.2% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Compass Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Compass Therapeutics reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Compass Therapeutics. You can switch it off at any time.
Alert me before CMPX reportsFree to start. Creating an account takes under a minute.
CMPX earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.12 |
| Last report | Aug 6, 2026 · Miss |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | +0.2% |
| Average move around a report | ±5.6% (last 5) |
| Sector | Healthcare · Biotechnology |
Compass Therapeutics earnings history: last 5 reports
Compass Therapeutics last reported on Aug 6, 2026: EPS of -$0.13 against an estimate of -$0.11 (-18.2% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.11 | -$0.13 | -18.2% | Miss | +13.8% |
| Jul 20, 2026 | $0.34 | $0.36 | +5.9% | Beat | +2.4% |
| Jun 4, 2026 | $1.45 | $1.64 | +13.1% | Beat | -2.9% |
| May 5, 2026 | -$0.10 | -$0.10 | 0.0% | In line | -3.6% |
| Apr 13, 2026 | $0.30 | $0.30 | 0.0% | In line | +5.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CMPX
See the fair value, the probability range and the earnings history of Compass Therapeutics on its ATLAS page.
Compass Therapeutics (CMPX) stock analysisPlans from €3.99 a month.
Compass Therapeutics earnings: frequently asked questions
When does Compass Therapeutics (CMPX) report earnings?
Compass Therapeutics is scheduled to report on Wednesday, November 4, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CMPX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.12 per share (USD). Estimates can change before the report.
How often does CMPX beat earnings estimates?
Of its last 5 reports with a recorded result, Compass Therapeutics beat the EPS estimate 2 times; the average surprise was +0.2%. Past results do not predict the next one.
How much does CMPX move around earnings?
Over its last 5 reports the stock moved an average of 5.6% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Compass Therapeutics beat earnings estimates last quarter?
Compass Therapeutics last reported on Aug 6, 2026: EPS of -$0.13 against an estimate of -$0.11 (-18.2% surprise), a miss.
How much does CMPX usually move in a day?
On a normal trading day the ATLAS model puts CMPX’s one-day range at about ±5.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer